Ghostine Pediatrics: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Ghostine Pediatrics
Largest movements
- Cash +€84,117
up €84,117 (+159%), from €52,807 to €136,924
mainly Net result for the year (+€61,646) and Depreciation (+€29,210)
- Intangible fixed assets -€29,000
down €29,000 (-21.9%), from €132,639 to €103,639
- Receivables within one year +€6,213
up €6,213 (+109%), from €5,709 to €11,922
of which Trade receivables: +€5,463
- Profit (loss) carried forward +€61,646
up €61,646 (+134%), from €46,007 to €107,654
- Other debts +€6,572
up €6,572 (+4.9%), from €134,180 to €140,752
- Tax, wage and social debts -€4,408
down €4,408 (-60.7%), from €7,257 to €2,848
- Gross operating margin +€35,884
up €35,884 (+43.5%), from €82,530 to €118,414
- Depreciation +€16,850
up €16,850 (+136%), from €12,361 to €29,210
- Taxes +€4,089
up €4,089 (+31.0%), from €13,200 to €17,289
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €191,155 | €254,103 | +€62,948 | +32.9% |
| Fixed assets | 21/28 | €132,639 | €105,257 | -€27,382 | -20.6% |
| Intangible fixed assets | 21 | €132,639 | €103,639 | -€29,000 | -21.9% |
| Tangible fixed assets | 22/27 | - | €1,618 | +€1,618 | |
| Furniture and vehicles | 24 | - | €1,618 | +€1,618 | |
| Current assets | 29/58 | €58,516 | €148,846 | +€90,330 | +154% |
| Amounts receivable within one year | 40/41 | €5,709 | €11,922 | +€6,213 | +109% |
| Trade receivables | 40 | €5,709 | €11,172 | +€5,463 | +95.7% |
| Other amounts receivable | 41 | - | €750 | +€750 | |
| Cash at bank and in hand | 54/58 | €52,807 | €136,924 | +€84,117 | +159% |
| Total equity and liabilities | 10/49 | €191,155 | €254,103 | +€62,948 | +32.9% |
| Equity | 10/15 | €48,507 | €110,154 | +€61,646 | +127% |
| Contributions | 10/11 | €2,500 | €2,500 | = | 0.0% |
| Profit (loss) carried forward | 14 | €46,007 | €107,654 | +€61,646 | +134% |
| Amounts payable | 17/49 | €142,648 | €143,949 | +€1,301 | +0.9% |
| Amounts payable within one year | 42/48 | €142,648 | €143,949 | +€1,301 | +0.9% |
| Trade debts | 44 | €1,211 | €349 | -€862 | -71.2% |
| Suppliers | 440/4 | €1,211 | €349 | -€862 | -71.2% |
| Taxes, remuneration and social security | 45 | €7,257 | €2,848 | -€4,408 | -60.7% |
| Taxes | 450/3 | €7,257 | €2,848 | -€4,408 | -60.7% |
| Other amounts payable | 47/48 | €134,180 | €140,752 | +€6,572 | +4.9% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €12,361 | €29,210 | +€16,850 | +136% |
| Other operating charges | 640/8 | €25 | €58 | +€33 | +132% |
| Gross operating margin | 9900 | €82,530 | €118,414 | +€35,884 | +43.5% |
| Operating profit (loss) | 9901 | €70,145 | €89,146 | +€19,001 | +27.1% |
| Financial income | 75/76B | - | €1 | +€1 | |
| Recurring financial income | 75 | - | €1 | +€1 | |
| Financial charges | 65/66B | €10,937 | €10,212 | -€725 | -6.6% |
| Recurring financial charges | 65 | €10,937 | €10,212 | -€725 | -6.6% |
| Profit (loss) for the period before taxes | 9903 | €59,207 | €78,935 | +€19,727 | +33.3% |
| Income taxes | 67/77 | €13,200 | €17,289 | +€4,089 | +31.0% |
| Profit (loss) for the period | 9904 | €46,007 | €61,646 | +€15,639 | +34.0% |
| Profit (loss) for the period to be appropriated | 9905 | €46,007 | €61,646 | +€15,639 | +34.0% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 26 October 2026 via checked.be.